LDL-C Management Trends in ASCVD Patients
Keith C. Ferdinand, MD
PeerPeter Izmirly, MD
PeerMarc Bonaca, MD
PeerNo benefit of routine spironolactone post-MI
Sanjit Jolly, MD
PeerSubodh Verma, MD, PhD
PeerStephen Nicholls, FRACP, FACC, FESC, FAHA
PeerFrom Symptoms to Diagnosis: Navigating ATTR Amyloidosis in Clinical Practice
Uncovering Unmet Needs in ATTR Amyloidosis
Unraveling Hereditary ATTR Amyloidosis: Key Variants and Clinical Insights
Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment
Breaking Down ATTR Pathophysiology
Marcus Anthony Urey, MD
PeerClinical Perspectives on Prioritizing LDL-C Management After a Recent Coronary Event
Kathleen Drinan, DO
Peer